Artificial cilia for soft and stable surface covalent immobilization of bone morphogenetic protein-2

被引:8
|
作者
Gan, Qi [1 ,2 ]
Chen, Lina [1 ]
Bei, Ho-Pan
Ng, Sze-Wing [1 ]
Guo, Han [4 ]
Liu, Guoqiang [1 ]
Pan, Hao [2 ]
Liu, Changsheng [2 ]
Zhao, Xin [3 ]
Zheng, Zijian [1 ,5 ]
机构
[1] Hong Kong Polytech Univ, Sch Fash & Text, Lab Adv Interfacial Mat & Devices, Hong Kong Special Adm Reg China, Kowloon, Peoples R China
[2] East China Univ Sci & Technol, Sch Mat Sci & Engn, Key Lab Ultrafine Mat Minist Educ, Shanghai 200237, Peoples R China
[3] Hong Kong Polytech Univ, Dept Biomed Engn, Hong Kong, Peoples R China
[4] Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai Synchrotron Radiat Facil, Shanghai 201204, Peoples R China
[5] Hong Kong Polytech Univ, Fac Sci, Dept Appl Biol & Chem Technol, Hong Kong Special Adm Reg China, Kowloon, Peoples R China
基金
中国国家自然科学基金;
关键词
Polymer brush; Poly (glycidyl methacrylate); Surface modification; Protein immobilization; Bioactivity; TISSUE-REPAIR; BMP-2; REGENERATION; SCAFFOLDS;
D O I
10.1016/j.bioactmat.2022.12.029
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Preservation of growth factor sensitivity and bioactivity (e.g., bone morphogenetic protein-2 (BMP-2)) post-immobilization to tissue engineering scaffolds remains a great challenge. Here, we develop a stable and soft surface modification strategy to address this issue. BMP-2 (a model growth factor) is covalently immobilized onto homogeneous poly (glycidyl methacrylate) (PGMA) polymer brushes which are grafted onto substrate surfaces (Au, quartz glass, silica wafer, or common biomaterials) via surface-initiated atom transfer radical polymeri-zation. This surface modification method multiplies the functionalized interfacial area; it is simple, fast, gentle, and has little effect on the loaded protein owing to the cilia motility. The immobilized BMP-2 (i-BMP-2) on the surface of homogeneous PGMA polymer brushes exhibits excellent bioactivity (-87% bioactivity of free BMP-2 in vitro and 20%-50% higher than scaffolds with free BMP-2 in vivo), with conformation and secondary structure well-preserved after covalent immobilization and ethanol sterilization. Moreover, the osteogenic activity of i-BMP-2 on the nanoline pattern (PGMA-poly (N-isopropylacrylamide)) shows-110% bioactivity of free BMP-2. This is superior compared to conventional protein covalent immobilization strategies in terms of both bioactivity preservation and therapeutic efficacy. PGMA polymer brushes can be used to modify surfaces of different tissue-engineered scaffolds, which facilitates in situ immobilization of growth factors, and accelerates repair of a wide range of tissue types.
引用
收藏
页码:551 / 562
页数:12
相关论文
共 50 条
  • [41] Regulation of scleral fibroblast differentiation by bone morphogenetic protein-2
    Li, Hong-Hui
    Huo, Li-Jun
    Gao, Zhen-Ya
    Zhao, Feng
    Zeng, Jun-Wen
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2014, 7 (01) : 152 - 156
  • [42] Regulation of scleral fibroblast differentiation by bone morphogenetic protein-2
    Hong-Hui Li
    Li-Jun Huo
    Zhen-Ya Gao
    Feng Zhao
    Jun-Wen Zeng
    International Journal of Ophthalmology, 2014, (01) : 152 - 156
  • [43] Bone Morphogenetic Protein-2 stimulates angiogenesis in developing tumors
    Langenfeld, EM
    Langenfeld, J
    MOLECULAR CANCER RESEARCH, 2004, 2 (03) : 141 - 149
  • [44] Use of bone morphogenetic protein-2 for adult spinal deformity
    Luhmann, SJ
    Bridwell, KH
    Cheng, I
    Imamura, T
    Lenke, LG
    Schootman, M
    SPINE, 2005, 30 (17) : S110 - S117
  • [45] Commentary: Important considerations on bone morphogenetic protein-2 and neuroinflammation
    Heggeness, Michael H.
    SPINE JOURNAL, 2011, 11 (06): : 506 - 506
  • [46] Regulation of growth plate chondrogenesis by bone morphogenetic protein-2
    De Luca, F
    Barnes, KM
    Uyeda, JA
    De-Levi, S
    Abad, V
    Palese, T
    Mericq, V
    Baron, J
    ENDOCRINOLOGY, 2001, 142 (01) : 430 - 436
  • [47] A novel biodegradable delivery system for bone morphogenetic protein-2
    Engstrand, Thomas
    Veltheim, Riikka
    Arnander, Claes
    Docherty-Skogh, Ann-Charlott
    Westermark, Anders
    Ohlsson, Claes
    Adolfsson, Lars
    Larm, Olle
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2008, 121 (06) : 1920 - 1928
  • [48] A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2
    James, Aaron W.
    LaChaud, Gregory
    Shen, Jia
    Asatrian, Greg
    Nguyen, Vi
    Zhang, Xinli
    Ting, Kang
    Soo, Chia
    TISSUE ENGINEERING PART B-REVIEWS, 2016, 22 (04) : 284 - 297
  • [49] RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 IN SPINE SURGERY
    Hsu, Wellington K.
    JBJS REVIEWS, 2014, 2 (06)
  • [50] Biotinated bone morphogenetic protein-2: In vivo and in vitro activity
    Uludag, H
    Golden, J
    Palmer, R
    Wozney, JM
    BIOTECHNOLOGY AND BIOENGINEERING, 1999, 65 (06) : 668 - 672